Physician profile
Jill A Mitchell
NPI 1134428022
$3,330.67
in general payments reported to CMS, 2019-2025
21 companies · $735 in 2025
The $735 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $554 · 2022: $414 · 2023: $713 · 2024: $915 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,362.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,299.17 | 2021-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $534.86 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Abbvie INC. | $295.88 | 2021-2025 | |
| Nevro Corp. | $277.43 | 2021-2024 | Senza |
| Tersera Therapeutics LLC | $241.57 | 2021-2025 | Prialt |
| Scilex Pharmaceuticals INC. | $135.43 | 2023-2025 | Ztlido |
| Globus Medical, INC. | $91.95 | 2025 | Senza |
| Abbott Laboratories | $90.97 | 2022 | |
| Boston Scientific Corporation | $53.65 | 2024 | Wavewriter Alpha Prime 16 |
| Biohaven Pharmaceuticals, INC. | $48.49 | 2021 | |
| Spr Therapeutics, INC | $42.66 | 2025 | Sprint Pns System |
| Travere Therapeutics, INC. | $37.07 | 2025 | |
| Uswm, LLC | $26.32 | 2023 | Zimhi, Lucemyra |
| Averitas Pharma INC. | $24.40 | 2025 | Qutenza |
| Biodelivery Sciences International, INC. | $24.36 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $23.91 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.83 | 2025 | |
| Almatica Pharma LLC | $18.34 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $16.80 | 2022 | |
| Bioventus LLC | $16.60 | 2023 | Stimrouter Implantable Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.